Mechanistic Insights Into NIR‐II AIEgens Boosted Multimodal Phototheranostics DOI Open Access
Jun Zhu,

Leyuan Tian,

Dingyuan Yan

и другие.

Small, Год журнала: 2024, Номер 21(6)

Опубликована: Дек. 29, 2024

Abstract Exploiting single molecular species synchronously affording powerful second near‐infrared (NIR‐II) fluorescence, superior photoacoustic output, prominent reactive oxygen generation, and satisfactory photothermal conversion is supremely appealing for phototheranostics, yet remains formidably challenging. In this work, electron donor/π‐bridge engineering implemented on the basis of 6,7‐di(thiophen‐2‐yl)‐[1,2,5]thiadiazolo[3,4‐ g ]quinoxaline moiety. The optimal molecule, namely TPATO‐TTQ, demonstrates to exhibit those notable features requested by exceptional which are systematically elucidated through depictions excited‐state energy dissipation pathways influence intramolecular motion photophysical properties, with assistances quantum chemical calculation dynamic simulation. By utilizing TPATO‐TTQ nanoparticles, unprecedented performance NIR‐II fluorescence‐photoacoustic‐photothermal trimodal imaging‐navigated type I photodynamic‐photothermal synergistic therapy orthotopic breast cancer authenticates precise tumor diagnosis complete ablation.

Язык: Английский

The Midas Touch by Iridium: A Second Near-Infrared Aggregation-Induced Emission-Active Metallo-Agent for Exceptional Phototheranostics of Breast Cancer DOI
Caifa You,

Leyuan Tian,

Jun Zhu

и другие.

Journal of the American Chemical Society, Год журнала: 2025, Номер 147(2), С. 2010 - 2020

Опубликована: Янв. 7, 2025

Developing small organic molecular phototheranostic agents with second near-infrared (NIR-II) aggregation-induced emission (AIE) is paramount for the phototriggered diagnostic imaging and synchronous in situ therapy of cancer via an excellent balance excited states energy dissipations. In this study, a multifunctional iridium(III) complex exploited by coordination AIE-active N^N ancillary ligand trivalent iridium ion. The resultant DPTPzIr significantly outperforms its parent terms absorption/emission wavelengths, reactive oxygen species (ROS) production, photothermal conversion, which simultaneously endow nanoparticles matched absorption peak to commercial 808 nm laser, longest NIR-II (above 1100 nm) among those previously reported AIE complexes, potentiated type-I ROS generation, as high 60.5% conversion efficiency. Consequently, perform well multimodal image-guided photodynamic therapy-photothermal breast tumor-bearing mice, enabling precise tumor diagnosis complete ablation biocompatibility. Our present work provides simple, feasible, effective paradigm development advanced agents.

Язык: Английский

Процитировано

3

Recent Advances in Strategies to Enhance Photodynamic and Photothermal Therapy Performance of Single‐Component Organic Phototherapeutic Agents DOI Creative Commons
Laiping Fang,

Zengzhen Chen,

Jianan Dai

и другие.

Advanced Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 10, 2025

Abstract Photodynamic therapy (PDT) and photothermal (PTT) have emerged as promising treatment options, showcasing immense potential in addressing both oncologic nononcologic diseases. Single‐component organic phototherapeutic agents (SCOPAs) offer advantages compared to inorganic or multicomponent nanomedicine, including better biosafety, lower toxicity, simpler synthesis, enhanced reproducibility. Nonetheless, how further improve the therapeutic effectiveness of SCOPAs remains a challenging research area. This review delves deeply into strategies performance PDT PTT by optimizing structural design SCOPAs. These encompass augmenting reactive oxygen species (ROS) generation, mitigating dependence, elevating light absorption capacity, broadening region, enhancing conversion efficiency (PCE). Additionally, this also underscores ideal for developing with balanced PTT. Furthermore, synergies are highlighted between other modalities such ferroptosis, gas therapy, chemotherapy, immunotherapy. By providing comprehensive analysis these strategies, aspires serve valuable resource clinicians researchers, facilitating wider application advancement SCOPAs‐mediated

Язык: Английский

Процитировано

2

Phototherapy: progress, challenges, and opportunities DOI
Xi Yuan,

Junliang Zhou,

Lin Yuan

и другие.

Science China Chemistry, Год журнала: 2024, Номер unknown

Опубликована: Дек. 5, 2024

Язык: Английский

Процитировано

10

Interstitial Optical Fiber‐Mediated Multimodal Phototheranostics Based on an Aggregation‐Induced NIR‐II Emission Luminogen for Orthotopic Breast Cancer Treatment DOI
Wenguang Zhang,

Miaomiao Kang,

Xue Li

и другие.

Advanced Materials, Год журнала: 2024, Номер 36(38)

Опубликована: Июль 26, 2024

Abstract One‐for‐all phototheranostics based on a single molecule is recognized as convenient approach for cancer treatment, whose efficacy relies precise lesion localization through multimodal imaging, coupled with the efficient exertion of phototherapy. To unleash full potential phototheranostics, advancement in both phototheranostic agents and light delivery methods essential. Herein, an integrated strategy combining versatile featuring aggregation‐induced emission, namely tBuTTBD, modified optical fiber to realize comprehensive tumor diagnosis “inside‐out” irradiation orthotopic breast tumor, proposed first time. Attributed intense donor‐acceptor interaction, highly distorted conformation, abundant molecular rotors, loose intermolecular packing upon aggregation, tBuTTBD can synchronously undergo second near‐infrared (NIR‐II) fluorescence photothermal photodynamic generation under laser irradiation, contributing trimodal NIR‐II fluorescence‐photoacoustic (PA)‐photothermal imaging‐guided The treatment further carried out following insertion fiber, which fabricated by splicing flat‐end air‐core fiber. This configuration aims enable effective situ phototherapy maximizing energy utilization therapeutic benefits. work not only enriches palette but also provides valuable insight exploring protocol practical treatment.

Язык: Английский

Процитировано

8

NIR‐II AIEgens for Infectious Diseases Phototheranostics DOI
Dingyuan Yan, Zheng Li, Michelle M. S. Lee

и другие.

Angewandte Chemie International Edition, Год журнала: 2024, Номер 63(51)

Опубликована: Авг. 26, 2024

Abstract Pathogenic infectious diseases have persistently posed significant threats to public health. Phototheranostics, which combines the functions of diagnostic imaging and therapy, presents an extremely promising solution block spread pathogens as well outbreak epidemics owing its merits a wide‐spectrum activity, high controllability, non‐invasiveness, difficult acquire resistance. Among multifarious phototheranostic agents, second near‐infrared (NIR‐II, 1000–1700 nm) aggregation‐induced emission luminogens (AIEgens) are notable by virtue their deep penetration depth, excellent biocompatibility, balanced radiative nonradiative decay aggregation‐enhanced theranostic performance, making them ideal option for combating pathogens. This minireview provides systematical summary latest advancements in NIR‐II AIEgens with emphasis on molecular design nanoplatform formulation fulfill high‐efficiency treating bacterial viral pathogens, classified disease models. Then, current challenges, potential opportunities, future research directions presented facilitate further progress this emerging field.

Язык: Английский

Процитировано

6

Red/near-infrared light triggered photorelease via sensitized photolysis DOI
Donghao Lu,

Shu Yang,

Qiyu Yu

и другие.

Coordination Chemistry Reviews, Год журнала: 2024, Номер 518, С. 216117 - 216117

Опубликована: Июль 27, 2024

Язык: Английский

Процитировано

5

Molecularly Manipulating Pyrazinoquinoxaline Derivatives to Construct NIR-II AIEgens for Multimodal Phototheranostics of Breast Cancer Bone Metastases DOI
Ping Zheng,

Xueke Yan,

Jun Zhu

и другие.

Biomaterials, Год журнала: 2025, Номер 317, С. 123105 - 123105

Опубликована: Янв. 11, 2025

Язык: Английский

Процитировано

0

Cancer-targeted and Biomarker-activated Fluorescent Probe for Diagnosis Imaging and Therapy DOI
Jianfei Liu,

Junmin Sun,

Di Zhang

и другие.

Sensors and Actuators B Chemical, Год журнала: 2025, Номер unknown, С. 137275 - 137275

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Electron-donating substituents allow boosted fluorescence emission wavelengths of Dihydropyridopyrazine functionalized xanthene DOI

Caidong Shuang,

Chong Hyun Chang, Pingping Sun

и другие.

Chemical Physics, Год журнала: 2025, Номер 593, С. 112641 - 112641

Опубликована: Фев. 7, 2025

Язык: Английский

Процитировано

0

Recent Advances in NIR-II Molecular Aggregates and Applications in the Biomedical Field DOI Creative Commons

Kun Wu,

Rong Yang,

Xuefang Song

и другие.

Chemosensors, Год журнала: 2025, Номер 13(2), С. 67 - 67

Опубликована: Фев. 13, 2025

Near-infrared (NIR) light is a promising tool for biomedical imaging and therapy, offering excellent tissue penetration, low scattering, minimal biological fluorescence interference. An NIR-II optical range of 900–1880 nm with reduced background interference particularly useful disease diagnosis treatment. Probes based on organic molecules are gaining attention their structural flexibility stable performance. Organic molecular aggregates, such as J-aggregates, H-aggregates, aggregation-induced emission (AIE)-aggregates, exhibit unique properties like tunable spectral shifts, improved photostability, higher absorption quantum yields. This mini review briefly discusses the advancements in therapy technologies, focusing classification, formation mechanisms, applications aggregates treatment, theoretical foundation practical guidance future research.

Язык: Английский

Процитировано

0